PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth under 50% of ADI's 33.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.28%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
8.28%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
8.59%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
9.81%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
9.48%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
9.66%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.11%
Share reduction more than 1.5x ADI's 31.17%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Dividend growth 1.25-1.5x ADI's 11.20%. Bruce Berkowitz would see if management’s capital return strategy is more aggressive yet sustainable.
-2.92%
Negative OCF growth while ADI is at 49.31%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-44.64%
Negative FCF growth while ADI is at 48.97%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
73.70%
10Y revenue/share CAGR at 50-75% of ADI's 101.28%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
52.56%
5Y revenue/share CAGR similar to ADI's 48.92%. Walter Schloss might see both companies benefiting from the same mid-term trends.
34.08%
3Y revenue/share CAGR above 1.5x ADI's 11.78%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
198.43%
10Y OCF/share CAGR 1.25-1.5x ADI's 151.82%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
83.17%
5Y OCF/share CAGR above 1.5x ADI's 23.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
13.33%
3Y OCF/share CAGR above 1.5x ADI's 0.44%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
782.06%
Positive 10Y CAGR while ADI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
120.11%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
77.97%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
49.67%
Below 50% of ADI's 516.72%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
37.23%
Below 50% of ADI's 369.87%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
52.90%
Below 50% of ADI's 163.74%. Michael Burry suspects a serious short-term disadvantage in building book value.
576.51%
10Y dividend/share CAGR above 1.5x ADI's 205.67%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.41%
5Y dividend/share CAGR above 1.5x ADI's 82.93%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
48.82%
3Y dividend/share CAGR at 75-90% of ADI's 57.83%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
2.90%
AR growth is negative/stable vs. ADI's 77.25%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.52%
Inventory shrinking or stable vs. ADI's 82.60%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.03%
Asset growth well under 50% of ADI's 141.77%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
9.61%
Under 50% of ADI's 136.17%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
6.03%
Debt shrinking faster vs. ADI's 31.47%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.26%
R&D dropping or stable vs. ADI's 30.17%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.94%
We cut SG&A while ADI invests at 54.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.